HOME >> Hubei Enterprises & Global Production Capacity Cooperation

Humanwell Healthcare Group Co., Ltd.

Source: hubei.gov.cn 06/03/2016 05:06:04

Eye on international markets, both US & Europe and Africa

"Whether it is the US & European markets, or the African market, the company should have strength to try," Wang Xuhai, the president of Humanwell Healthcare Group Co., Ltd said.

Between 2009 and 2010, Humanwell set up R & D center and sales team in the U.S. And in May of 2015, it certified by the U.S. FDA at an outstanding performance, becoming the first FDA-cleared preparation enterprise in Hubei.

In 2015, Humanwell achieved sales of more than 50 million U.S. dollars in US market listed among top 3 of the soft capsule suppliers. It is expected that the sales in this country will break through 200 million U.S. dollars.

When it came to the African market, Humanwell invested 300 million yuan in building factories in Mali in 2013, making the project a modern large pharmaceutical plant with most investment and largest scale in western Africa from China.

"The Mali plant faces the whole west African market," Wang Xuehai said, adding that an annual sales of 400 million yuan was expected to reach after the plant to be operational, and another plant in Ethiopia with an investment of 300 million yuan is being planned.